ProtoMed: Drugs from soybeans By Karen Bernstein

Having watched the "early commercialization" strategies at a variety of biotech companies, ProtoMed Inc. President and CEO Louis Scotti thinks he's learned something: the strategy of buying in existing products can't be the basis of an entire company, and it only works if the price is right.